TriCor FDA Approval History
FDA Approved: Yes (First approved November 5, 2004)
Brand name: TriCor
Generic name: fenofibrate
Dosage form: Tablets
Company: AbbVie Inc.
Treatment for: Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia, Hyperlipoproteinemia Type IV, Elevated VLDL, Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL, Hypertriglyceridemia
TriCor (fenofibrate tablets) is a lipid regulating agent indicated for the treatment of hypercholesterolemia and hypertriglyceridemia.
Development timeline for TriCor
| Date | Article |
|---|---|
| Nov 5, 2004 | Approval TriCor Abbott Laboratories - Treatment for Lipid Disorders |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.